Abstract
Endothelin (ET) may mediate the enhanced coronary vasoconstriction associated with hypercholesterolemia. We hypothesized that short-term inhibition of ET receptors attenuates the coronary epicardial vasoconstrictor response to acetylcholine in experimental hypercholesterolemia. ET-1 (group I, n=5; 5 ng x kg[-1] x min[-1]) and acetylcholine (group III, n=7; 10[-6] to 10[-4] mol/L) were given by intracoronary infusion in pigs. ET-1 and acetylcholine were also infused with the specific ETA-receptor blocker FR-139317 (5 microg x kg[-1] x min[-1]; group II, n=6; group IV, n=6). Acetylcholine was also infused with the combined ET-receptor blocker, bosentan (0.5 mg/kg plus 1 mg x kg[-1] x h[-1], group V, n=5). The ETB-receptor agonist sarafotoxin 6c (5 ng x kg[-1] x min[-1]; n=4) was also infused. The percentage change in coronary artery diameter (%deltaCAD) to the infusions was measured at baseline and after 10 weeks of high-cholesterol diet in all animals. Sarafotoxin 6c mildly reduced %deltaCAD at baseline and 10 weeks (-10+/-2% and -12+/-3%, respectively). FR-139317 did not attenuate the epicardial vasoconstrictor response to ET-1 at baseline (%deltaCAD -18+/-8% for group I versus -12+/-6% for group II; P=NS) but did at 10 weeks (...Continue Reading
References
Mar 1, 1992·British Journal of Pharmacology·V J HarrisonP Schoeffter
Jan 1, 1991·Journal of Cardiovascular Pharmacology·R H BeckerW Linz
Jan 23, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Oct 13, 1991·The New England Journal of Medicine·A LermanJ C Burnett
Jan 1, 1991·American Journal of Hypertension·T InagamiS Nakajo
Dec 20, 1990·Nature·H AraiS Nakanishi
Dec 20, 1990·Nature·T SakuraiT Masaki
Jul 1, 1990·The Journal of Clinical Investigation·M A CreagerV J Dzau
Mar 1, 1990·Hypertension·A V ChobanianR Drago
Jan 1, 1985·Catheterization and Cardiovascular Diagnosis·A A BoveR E Vlietstra
Aug 10, 1995·The New England Journal of Medicine·E R Levin
Nov 1, 1994·Cardiovascular Research·S M KrauseR F Woltmann
Jul 18, 1994·FEBS Letters·F Fukamauchi, D M Chuang
Mar 1, 1994·The International Journal of Biochemistry·M Sokolovsky
Oct 26, 1993·European Journal of Pharmacology·J Pernow, A Modin
Sep 1, 1993·Diabetes·K ShimizuT Ito
Feb 1, 1993·British Journal of Pharmacology·L O CardellL Edvinsson
Mar 31, 1993·Biochemical and Biophysical Research Communications·J A WinklesP Libby
Jan 1, 1995·Journal of Cardiovascular Pharmacology·Q D WangJ Pernow
Mar 1, 1996·The Journal of Clinical Investigation·A L ClavellJ C Burnett
Jan 1, 1996·Journal of Cardiovascular Pharmacology·P H DagassanJ P Clozel
Aug 1, 1996·Mayo Clinic Proceedings·V MathewA Lerman
Jul 1, 1996·American Heart Journal·J M Erikson, C E Velasco
Mar 1, 1996·International Journal of Cardiology·D HasdaiA Lerman
Jan 1, 1997·Catheterization and Cardiovascular Diagnosis·M R BellR S Schwartz
Citations
Mar 6, 2002·Lipids·Lars Lind
Feb 25, 1999·Atherosclerosis·D HasdaiA Lerman
Aug 25, 2010·Circulation·Martin RerianiAmir Lerman
May 14, 1998·The Journal of Laboratory and Clinical Medicine·C R CannanA Lerman
Jul 11, 2001·Journal of Cardiovascular Pharmacology·E Thorin
May 2, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Alexei V Agapitov, William G Haynes
Jul 4, 2003·Canadian Journal of Physiology and Pharmacology·Michel Lavallée, Eric Thorin
Oct 17, 2003·Coronary Artery Disease·Matthias BartonChristian C Haudenschild
Apr 17, 2021·American Journal of Physiology. Heart and Circulatory Physiology·Brielle L DotsonSteven K Malin